1-4 of 4
Authors: Manica Balasegaram
Save search
Sort by
Journal Article

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study

PDF
Thomas P C Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 11, November 2017, Pages 3131–3140, https://doi.org/10.1093/jac/dkx283
Published: 06 September 2017
Journal Article

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis Get access

PDF
Thomas P. C. Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 11, November 2012, Pages 2576–2597, https://doi.org/10.1093/jac/dks275
Published: 24 July 2012
Journal Article

Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine Get access

PDF
Thomas P. C. Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 8, August 2012, Pages 1996–2004, https://doi.org/10.1093/jac/dks164
Published: 10 May 2012
Journal Article

A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan Get access

PDF
Marius Mueller and others
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 4, October 2006, Pages 811–815, https://doi.org/10.1093/jac/dkl342
Published: 17 August 2006